Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02781220 · ClinicalTrials.gov registry record
Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial
A clinical trial, sponsored by University of Utah.
- Terminated
- Registry status
- 69
- Enrollment target
NCT02781220 is a clinical trial that was terminated before completion, run by University of Utah. The registered enrollment target is 69 participants.
The verdict
NCT02781220 was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- 69 participants
- Enrollment target
Study Summary
The main purpose of this study is to build upon the evidence captured in the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS; NCT02420756) trial to include valuable information regarding patient-reported outcomes and physician confidence in diagnosis and management based on the Implications for Management of PET Amyloid Classification Technology (IMPACT; NCT number not yet assigned) trial design.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2016-07 |
| Est. Completion | 2023-06-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02781220
The ClinicalTrials.gov registry entry for NCT02781220 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02781220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02781220 about?
NCT02781220 is a clinical study titled "Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial". The main purpose of this study is to build upon the evidence captured in the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS; NCT02420756) trial to include valuable information regarding patient-reported outcomes and physician confidence in diagnosis and management based on the Implications ...
What is the current status of trial NCT02781220?
This trial is currently terminated. The enrollment target is 69 participants. The study started on 2016-07. Estimated completion is 2023-06-10.
Who is sponsoring clinical trial NCT02781220?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.